This alert discusses the dosing errors when using an ultra-long-acting insulin as Tresiba®. Tresiba® FlexTouch® is available in two strengths – 100 units/mL and 200 units/mL. Users have been in ...
This safety notice is to raise awareness of two different insulin aspart formulations, namely Fiasp® and NovoRapid®. Fiasp® has a faster onset of action than NovoRapid® and a delay in food intake ...
This safety notice highlights the potential medication incidents which could occur with new labelling of concentrated potassium chloride by Pfizer. The previous labelling of 10 mmol (0.75 g) in 10 ...